Market Overview

Benzinga's Top Downgrades

Benzinga's Top Downgrades
Related TEVA
Top Performing Industries For December 1, 2015
US Stock Futures Edge Higher Ahead Of Economic Data
Premarket Biotech Digest: FibroGen's Gains, Anavex Data, Geron Rallies (Seeking Alpha)
Related QEP
Morning Market Gainers
Mid-Afternoon Market Update: Cracker Barrel Drops Following Q4 Results; Intra-Cellular Therapies Shares Jump

Analysts at JP Morgan downgraded Teva Pharmaceutical Industries (NYSE: TEVA) from “overweight” to “neutral.” The target price for Teva has been lowered from $45 to $43. Teva's shares closed at $38.88 yesterday.

Deutsche Bank downgraded QEP Resources (NYSE: QEP) from “buy” to “hold.” The target price for QEP Resources has been lowered from $37 to $34. QEP Resources' shares closed at $28.78 yesterday.

Baird downgraded Brady (NYSE: BRC) from “outperform” to “neutral.” The target price for Brady has been lowered from $41 to $33. Brady's shares closed at $30.52 yesterday.

Analysts at DA Davidson downgraded Under Armour (NYSE: UA) from “buy” to “neutral.” Under Armour's shares closed at $80.59 yesterday.

Latest Ratings for TEVA

Nov 2015Goldman SachsUpgradesNeutralBuy
Sep 2015NomuraInitiates Coverage onNeutral
Aug 2015Goldman SachsReinstatesBuy

View More Analyst Ratings for TEVA
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings


Related Articles (BRC + QEP)

View Comments and Join the Discussion!

Get Benzinga's Newsletters